KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash & Equivalents (2016 - 2026)

Bausch Health Companies' Cash & Equivalents history spans 18 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 14.55% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 14.55% increase, with the full-year FY2025 number at $1.3 billion, up 10.84% from a year prior.
  • Cash & Equivalents hit $1.3 billion in Q1 2026 for Bausch Health Companies, down from $1.3 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for BHC hit a ceiling of $1.7 billion in Q2 2025 and a floor of $486.0 million in Q3 2022.
  • Historically, Cash & Equivalents has averaged $927.5 million across 5 years, with a median of $760.0 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: crashed 58.53% in 2023 and later skyrocketed 190.25% in 2025.
  • Tracing BHC's Cash & Equivalents over 5 years: stood at $564.0 million in 2022, then skyrocketed by 67.91% to $947.0 million in 2023, then increased by 24.71% to $1.2 billion in 2024, then grew by 10.84% to $1.3 billion in 2025, then dropped by 0.76% to $1.3 billion in 2026.
  • Business Quant data shows Cash & Equivalents for BHC at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.